INTERESTING TRANSCATHETER ELECTROSURGERY CASES

Monday, March 10, 2025

4:44 PM – 5:34 PM ET

Moderator(s)

Rim Halaby, MD

Interventional Cardiologist/Staff Clinician
National Institutes of Health/National Heart, Lung, and Blood Institute

Disclosure(s): No financial relationships to disclose
Jaffar M. Khan, MD, PhD

Director of Cardiovascular Innovation and Director of Interventional Electrosurgery
St Francis Hospital and Heart Center
Roslyn, New York, United States

Disclosure(s): Abbott, Edwards Lifesciences, Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Cuspa medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Transmural Systems, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Panel Discussant(s)

Dan Haberman, MD

Consultant Cardiologist
MedStar Washington Hospital Center
Tel aviv, Israel

Disclosure(s): No financial relationships to disclose
Howard C. Herrmann, MD, FACC, MSCAI

Section Chief Interventional Cardiology
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States

Disclosure(s): Abbott: Grant/Research Support (Ongoing); Affluent Medical: Consultant (Ongoing); Caranx: Consultant (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Massachusetts Medical Society: Editorial consultant (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing); Microinterventional Devices: Consultant (Ongoing); Shockwave: Grant/Research Support (Ongoing); Wells Fargo: Consultant (Ongoing)
Giorgio A. Medranda, MD

Structural Interventional Cardiologist
NYU Langone Hospital - Long Island
Glen Cove, New York, United States

Disclosure(s): No financial relationships to disclose
Jeremy D. Rier, DO

Interventional Cardiologist
WellSpan Health

Disclosure(s): Abbott Cardiovascular Systems: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edward Lifesciences: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Disclosure(s):

Rim Halaby, MD: No financial relationships to disclose

Jaffar M. Khan, MD, PhD: Abbott, Edwards Lifesciences, Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Cuspa medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Transmural Systems, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Dan Haberman, MD: No financial relationships to disclose

Howard C. Herrmann, MD, FACC, MSCAI: Abbott: Grant/Research Support (Ongoing); Affluent Medical: Consultant (Ongoing); Caranx: Consultant (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Massachusetts Medical Society: Editorial consultant (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing); Microinterventional Devices: Consultant (Ongoing); Shockwave: Grant/Research Support (Ongoing); Wells Fargo: Consultant (Ongoing)

Giorgio A. Medranda, MD: No financial relationships to disclose

Jeremy D. Rier, DO: Abbott Cardiovascular Systems: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edward Lifesciences: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)